ID: ALA4041000
Type: ADME
Description: Drug metabolism in human hepatocytes assessed as cytosolic carbonyl reductase-mediated N-(4-amino-3-hydroxy-4-oxo-1-phenylbutan-2-yl)-2-(3-(4-fluorophenyl)-1H-pyrazol-1-yl)nicotinamide metabolite formation
Organism: Homo sapiens
Bioactivity
Activity Types for Assay ALA4041000
Drug metabolism
Parent Molecular Weight | ALogP | Polar Surface Area |
---|---|---|
457.47 | 2.47 | 2.47 |